Items where Author is "Rawstron, AC"

Journal article

ROBINSON, J.I., MD YUSOF, M.Y., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J.C., EL-SHERBINY, Y., MORRIS, D.L., LIU, L., RAWSTRON, A.C., BUCH, M.H., PLANT, D., CORDELL, H.J., ISAACS, J.D., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T.J., BARRETT, H., VITAL, E.M. and MORGAN, A.W., 2022. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. EBioMedicine, 86: 104343. ISSN 2352-3964

YUSOF, M.Y.M., ROBINSON, J.I., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J.C., EL-SHERBINY, Y., MORRIS, D.L., LIU, L., RAWSTRON, A.C., BUCH, M.H., PLANT, D., CORDELL, H., ISAACS, J.D., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T.J., BARRETT, J.H., VITAL, E.M. and MORGAN, A.W., 2022. OA13 Comprehensive genetic and functional analyses of Fc gamma receptors explain response to rituximab therapy for autoimmune rheumatic diseases. Rheumatology, 61 (S1). ISSN 1462-0332

MD YUSOF, M.Y., SHAW, D., EL-SHERBINY, Y.M., DUNN, E., RAWSTRON, A.C., EMERY, P. and VITAL, E.M., 2017. Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 76 (11), pp. 1829-1836. ISSN 0003-4967

DAS, S., VITAL, E.M., HORTON, S., BRYER, D., EL-SHERBINY, Y., RAWSTRON, A.C., PONCHEL, F., EMERY, P. and BUCH, M.H., 2014. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5), pp. 909-912. ISSN 0003-4967